A Non-interventional Prospective Observational Study to Understand the Usage Pattern of Ticagrelor in Indian Patients With Acute Coronary Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms TREASURE
- Sponsors AstraZeneca
- 13 Jul 2017 Status changed from active, no longer recruiting to completed.
- 27 Jun 2017 Planned End Date changed from 30 May 2017 to 30 Jun 2017.
- 27 Jun 2017 Planned primary completion date changed from 30 May 2017 to 30 Jun 2017.